Inside & Out. Clear Melasma in a Whole New Way.
The Aerolase Neo Elite® laser safely and effectively treats melasma on all skin types — even skin of color.

Different Forms of Melasma
Sun damage that frequently appear on the face, hands, and arms. Tend to be small, darkened patches of skin.
Result of inflammation duced by cutaneous diseases, often associated with acne, folliculitis, and eczema.
Tan and/or dark facial skin discoloration, with symptoms including dark, irregular patches commonly found on the cheeks, nose, lips, and forehead.
Traditional Treatment Limitations such as Topicals, Chemical Peels, and Other Laser Therapies:

How Aerolase technology reduces and removes Melasma
The Nd:YAG 1064nm laser is versatile, absorbed by melanin, hemoglobin, and water.
The laser targets deeper melanin in the dermis, bypassing epidermal melanin, allowing higher efficacy and a greater margin of safety on all skin types.
The laser targets hemoglobin to breakdown the vascular components in melasma.
Finally, the laser targets the water in the skin to superheat the dermal tissue and stimulate neocollagensis, enhancing the overall skin tone & texture.
50% improvement in melasma as early as 3 weeks after treatment with the Neo.
Results Showcase

.avif)


Customer testimonials



Melasma & hyperpigmentation treatment FAQ
Aerolase devices utilize 650-microsecond pulse duration technology that selectively targets melanin while minimizing heat diffusion to surrounding tissues. This unique pulse duration allows for effective treatment of epidermal and dermal pigmentation with reduced risk of post-inflammatory hyperpigmentation (PIH), making it particularly suitable for darker skin types (Fitzpatrick IV-VI) that are often contraindicated for traditional Q-switched lasers.
Clinical studies demonstrate 50-80% improvement in melasma after 4-6 treatment sessions spaced 2-4 weeks apart. The technology's ability to target both superficial and deep pigmentation makes it effective for mixed-type melasma. Patients typically see initial improvement after 2-3 sessions, with continued improvement for 2-3 months post-treatment as cellular turnover occurs.
Yes, Aerolase is considered one of the safest laser options for all Fitzpatrick skin types, including darker skin. The 650-microsecond pulse duration minimizes thermal damage and significantly reduces the risk of PIH compared to nanosecond lasers. However, proper treatment parameters and pre/post-treatment protocols remain essential for optimal safety outcomes.
The standard protocol involves 4-6 sessions spaced 2-4 weeks apart. Treatments are typically well-tolerated with minimal downtime—patients may experience mild erythema for 1-24 hours post-treatment. Unlike ablative procedures, patients can return to normal activities immediately, making it ideal for busy professionals seeking cosmetic improvement without significant recovery time.
Pre-treatment preparation includes discontinuing retinoids 3-5 days prior, using broad-spectrum SPF 30+ for 2-4 weeks beforehand, and considering hydroquinone pre-treatment for stubborn cases. Post-treatment care emphasizes strict sun protection, gentle skincare, and avoiding exfoliating agents for 48-72 hours. Maintenance treatments every 3-6 months are often recommended.
Melasma treatment packages typically range from $1,200-2,400 for a series of 4-6 sessions, with individual treatments priced at $250-450 depending on treatment area and market. Given the high demand for melasma treatment and limited effective options, practices often see strong patient retention and referral rates. The minimal consumable costs and quick treatment times (15-20 minutes) contribute to favorable profit margins.
Aerolase offers several advantages: lower PIH risk than fractional lasers, better deep pigment penetration than chemical peels, and more consistent results than IPL across all skin types. While combination therapy (Aerolase + topicals) often yields optimal results, the laser can be used as monotherapy. Unlike some alternatives, Aerolase doesn't require seasonal timing restrictions and has minimal risk of paradoxical darkening when properly administered.
Transform Your Melasma Strategy
Enhance patient outcomes and boost your practice revenue.